DRUG · Mapped RxNorm record
Cisplatin
Normalized identity: cisplatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
NCT02611037
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Methotrexate
Normalized identity: methotrexateView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Gemcitabine
Normalized identity: gemcitabineView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Lung Cancer Symptom Scale for Mesothelioma Questionnaire
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTransarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
CisplatinDRUG · verified · RxNorm: cisplatin
MethotrexateDRUG · verified · RxNorm: methotrexate
GemcitabineDRUG · verified · RxNorm: gemcitabine
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02611037 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.